Skip to content
BGS

B&G Foods, Inc.

B&G Foods, Inc. Q3 FY2025 earnings call

November 5, 2025 · fiscal period ended 2025-09

EPS · actual vs est

$0.15 / $0.11Beat +36.4%

Revenue · actual vs est

$439.3M / $537.5MMiss -18.3%
Ask about this call

Summary

Generated 2025-11-05

Management highlights

Management Statement and Operational Highlights

  • Q3 Results: Net sales were $439.3 million, down 4.7% y-o-y; base business net sales (excluding divestitures) were down 2.7%. Adjusted EBITDA was $70.4 million, flat y-o-y excluding divestitures.
  • Portfolio Divestitures: Divested Don Pepino, Sclafani, and Le Sieur U.S. brands in Q3; announced divestiture of Canadian Green Giant (subject to regulatory approval); evaluating divestiture of Green Giant U.S. frozen business.
  • Cost Savings: Implemented a $10 million cost savings initiative, with SG&A down $2 million and COGS as a percentage of net sales improving by 40 basis points.
  • Fiscal 2025 Outlook: Revised net sales guidance to $1.82 billion to $1.84 billion and adjusted EBITDA to $273 million to $280 million. Aim to reduce consolidated leverage ratio to 6x within 9 months using divestiture proceeds and excess cash.
View in transcript ↓

Segment performance

Segment Performance

  • Frozen & Vegetables: Base business net sales declined by $5.4 million or 6.7% in Q3, but segment adjusted EBITDA increased by $3 million due to more favorable crop pack costs and strong productivity in the Mexico facility.
  • Spices & Seasonings: Net sales grew +2.1% in Q3, but segment adjusted EBITDA was down approximately $2.1 million due to higher raw material costs and tariffs. Pricing actions were implemented to offset these costs.
  • Meals: Net sales decreased by $1.6 million or 1.4% in Q3, but segment adjusted EBITDA increased by approximately $0.6 million.
  • Specialty: Base business net sales decreased by approximately $7 million or 4.5% in Q3, with Crisco contributing significantly to the decline. Segment adjusted EBITDA was down $3.6 million or 8.7%.
View in transcript ↓

Guidance

Guidance

  • Revised net sales for fiscal 2025 to $1.82 billion to $1.84 billion and adjusted EBITDA to $273 million to $280 million.
  • Expect Q4 to show continued improvement vs H1 2025, with 53rd week adding 2%-3% sales growth. Base business net sales projected to be down ~2%-3% in Q4.
  • Aim to reduce consolidated leverage ratio to 6x within the next 9 months by using divestiture proceeds and excess cash from improved EBITDA and lower working capital needs.
View in transcript ↓

Risks

Risks

  • Challenges in the consumer environment.
  • Greater-than-expected negative volume impact from pricing initiatives to offset tariffs.
  • Trade negotiations and potential increased/retaliatory tariffs.
  • Soft holiday season or retail inventory management issues.
View in transcript ↓

Q&A highlights

Question and Answer

  • Q: Andrew Lazar from Barclays asks about Q4 sales and broader environment causing guidance shift.

A: Kenneth Keller responds that sales guidance was narrowed due to reflecting divestitures fully and keeping base business net sales trends consistent with Q3.

  • Q: Scott Marks from Jefferies asks about base business performance in Q4 excluding Green Giant and Frozen & Vegetables.

A: Kenneth Keller states expected more stable performance from Spices & Seasoning, Meals, and Baking Staples businesses.

  • Q: Robert Moskow from TD Cowen asks about leverage target and Green Giant divestitures.

A: Bruce Wacha explains leverage target assumes completion of divestitures and stabilization of EBITDA, excess cash, and working capital.

  • Q: William Reuter from Bank of America asks about shelf space and Green Giant U.S. sale timeline.

A: Bruce Wacha and Kenneth Keller mention forecast includes distribution wins/losses and progress on Green Giant U.S. divestiture.

  • Q: David Palmer from Bank of America asks about organic sales and all-channel performance.

A: Kenneth Keller explains base business trend includes measured and unmeasured channels, with 53rd week adding sales growth in Q4.

  • Q: Hale Holden from Barclays asks about spices pricing and Canada sale proxy.

A: Bruce Wacha and Kenneth Keller discuss spices pricing implementation and Canada sale proxy related to inventory.

  • Q: Carla Casella from JPMorgan asks about working capital anomaly in Q3.

A: Bruce Wacha explains inventory purchases for divested brands and reimbursement in Q4.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.15$0.11+36.4%
Revenue$439.3M$537.5M-18.3%

Transcript

November 5, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.